Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2777 participants.
Also called NCT01531374
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,777 participants
- Sponsor
- Registry
-
NCT01531374
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01531374. Non-randomized; no masking; primary purpose treatment. Start 2012-02-21 (actual); primary completion 2015-11 (actual). Results posted on 2017-07-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
- Condition
- Severe Aortic Stenosis
- Intervention (Device)
- Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct01531374- Content hash
913ac1ee4de491f74306e5800f5a0b718cfc194589b5849eaf3b46d1ed3677f4